Home|Journals|Articles by Year

Directory for Medical Articles
 

Research Article

JCDR. 2021; 12(5): 533-538


TO STUDY THE EFFECT OF COMBINATION OF METFORMIN, GLIMEPRIDE VOGLIBOSE IN TCF7L2 GENE ASSOCIATED TYPE 2 DIABETES MELLITUS.

Ksheerasagar Vinay Kumar, Dr. Anil Kumar, Dr. Pranjal Pankaj, Dr. Nilam Nigam.


Abstract

Background:The TCF7L2-gene (TCF7L2; Transcription factor 7-like 2) involves in regulation of cellular
proliferation and differentiation. It also increased risk for type 2 diabetes (T2D), dose effect were reported for
the rs7903146 variant. The risk alleles of TCF7L2 gene involves in progression of impaired glucose tolerance to
diabetes prospectively and an increased severity of the disease
Material and Methods:Prospective, randomised study. Combination of Metformin, Glimepride Voglibosehas
been prescribed in TCF7L2 gene associated type 2 diabetes mellitus patients s
Results: TCF7L2 gene is associated with Type 2 diabetes mellitus. Genetic investigation was done in all 40
patients three genotypes have been identified 10 patients were on CC, 12 patients were on CT and 18 patients
were on TT genotypes.Baseline values are higher in TT genotype when compared with CT & CC genotypes.
There were significant improvement in blood glucose levels were as a controlled lipid profile was observed in
CC genotype but no significant was observed in CT, TT and in group
Conclusion:Patients HbA1c ranges from

Key words: TCF7L2 gene, metformin, Glimepride, voglibose






Full-text options


Share this Article



Online Article Submission
• ejmanager.com







eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.